• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS ACCESS SOLUTION; CATHETER, SEPTOSTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS ACCESS SOLUTION; CATHETER, SEPTOSTOMY Back to Search Results
Lot Number VXFA020622
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Arrest (1762); Low Blood Pressure/ Hypotension (1914); Cardiac Perforation (2513); Pericardial Effusion (3271)
Event Date 02/26/2024
Event Type  Death  
Event Description
It was reported a patient death occurred.During a watchman left atrial appendage closure (laac) procedure to treat atrial fibrillation (a fib), a versacross access solution kit was selected for use.The intracardiac echocardiography (ice) was used to clear thrombus from pulmonary artery.Immediately upon going transseptal puncture, the blood pressure tanked, heart rate rose and a large effusion was noted.A pericardial access was achieved, and tapping was continuous, but effusion was not resolving.The physician decided to place the watchman device to try to slow the bleeding as the angiogram showed some dye extrapolation was seen out of the appendage.The effusion started to get slightly better with continuous tapping.The patient coded and compressions were started along with intubation.The surgery was called and cracked the chest but they could not get the patient heart to restart and the patient passes away on the table.In the physician opinion the versacross wire lacerated the left atrial appendage (laa).The device is not expected to be returned for analysis.It was further confirmed there was no thrombus present in pa (pulmonary artery).No issues were noted during tsp, which was achieved in first attempt with no track up and down.The pericardial effusion (pe) was located everywhere which was noted almost immediately after the tsp.Heparin was administered at groin access.Protamine was given after pericardial effusion was noted.Immediately after crossing the versacross wire went into the mouth of the appendage and was moved to the vein.The was sheath was not across when the pe was noticed.During surgery they found that the back of the appendage had a large hole.It was somehow lacerated open by the entrance of the wire into the prior to moving to the vein.
 
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS ACCESS SOLUTION
Type of Device
CATHETER, SEPTOSTOMY
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on L4W 5 P6
CA   L4W 5P6
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key18949057
MDR Text Key338232110
Report Number2124215-2024-16252
Device Sequence Number1
Product Code DXF
UDI-Device Identifier00685447011729
UDI-Public00685447011729
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K150709
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/21/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/21/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot NumberVXFA020622
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/26/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/20/2022
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Death; Life Threatening;
Patient Age86 YR
Patient SexFemale
Patient RaceWhite
-
-